XML 43 R26.htm IDEA: XBRL DOCUMENT v3.25.4
Note 2 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Exercise price per warrant

 $33.00 

Conversion rate - common shares per warrant

  1.50 

Closing price of common stock

 $23.72 

Volatility

  75%

Risk-free interest rate

  5.40%

Expected life of option (in years)

  0.3 

Dividend yield

 

zero

 
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Years Ended December 31,

 
  

2025

  

2024

  

2023

 

Operating expenses

            

Research and development

 $26,590  $69,637  $89,423 

General and administrative

  68,800   71,809   16,534 

Other segment items(a)

  (4,417)  (117,104)  (8,740)

Net loss

 $90,973  $24,342  $97,217 
  

December 31,

 
  

2025

  

2024

 

Cash and cash equivalents

 $95,502  $128,574 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Years ended December 31,

 
  

2025

  

2024

  

2023

 

Numerator, basic:

            

Net loss

 $(90,973) $(24,342) $(97,217)

Denominator, basic:

            

Weighted average common shares outstanding

  48,297   46,329   41,932 

Net loss per share, basic

  (1.88)  (0.53)  (2.32)
             

Numerator, diluted:

            

Net loss

 $(90,973) $(24,342) $(97,217)

Adjustment for change in fair value of warrant liabilities

     (43,793)   

Adjusted numerator, diluted

 $(90,973) $(68,135) $(97,217)

Denominator, diluted:

            

Weighted average common shares outstanding

  48,297   46,329   41,932 

Dilutive effect of common stock warrants

     275    

Weighted average dilutive common shares

  48,297   46,604   41,932 

Net loss per share, diluted

 $(1.88) $(1.46) $(2.32)
             

Dilutive common stock options excluded from net loss per share, diluted

  3,940   3,154   2,123 

Dilutive Performance Awards excluded from loss per share, diluted

  7   7   7